Literature DB >> 35534716

The role of microbiota in colorectal cancer.

Azar Dokht Khosravi1,2, Sakineh Seyed-Mohammadi3, Ali Teimoori4, Aram Asarehzadegan Dezfuli5,3.   

Abstract

Cancer is one of the most important causes of death throughout the world, and the mortality rate is increasing significantly due to the aging of the population. One of the most common types of cancer is colorectal cancer (CRC). Human microbial ecosystems use metabolism to make important impacts on the body physiology. An intensive literature review was made to investigate the correlations between human gut microbiota and the incidence of CRC. The results of these studies show that there are differences in the composition of microbiota between CRC patients and normal people and the microorganisms in CRC patients are very different from healthy individuals. Therefore, changes in the microbiome can be used as a biomarker for the early detection of CRC. On the other hand, the intestinal flora is may be act as a powerful weapon against CRC in the future.
© 2022. Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i.

Entities:  

Keywords:  Bacteriology; Colorectal cancer; Gastrointestinal; Microbiome; Vaccine

Mesh:

Year:  2022        PMID: 35534716     DOI: 10.1007/s12223-022-00978-1

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  61 in total

Review 1.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Virology       Date:  2011-01-08       Impact factor: 3.616

Review 2.  Probiotic mechanisms of action.

Authors:  Miriam Bermudez-Brito; Julio Plaza-Díaz; Sergio Muñoz-Quezada; Carolina Gómez-Llorente; Angel Gil
Journal:  Ann Nutr Metab       Date:  2012-10-02       Impact factor: 3.374

Review 3.  Gut Microbiota, Inflammation, and Colorectal Cancer.

Authors:  Caitlin A Brennan; Wendy S Garrett
Journal:  Annu Rev Microbiol       Date:  2016-09-08       Impact factor: 15.500

4.  The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease.

Authors:  Annemarie Boleij; Harold Tjalsma
Journal:  Lancet Infect Dis       Date:  2013-07-05       Impact factor: 25.071

Review 5.  Immunotherapy in colorectal cancer: for the select few or all?

Authors:  Sukeshi Patel Arora; Devalingam Mahalingam
Journal:  J Gastrointest Oncol       Date:  2018-02

6.  An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine.

Authors:  R Curtis Bird; Patricia Deinnocentes; Allison E Church Bird; Frederik W van Ginkel; Joni Lindquist; Bruce F Smith
Journal:  Cancer Immunol Immunother       Date:  2010-11-11       Impact factor: 6.968

7.  Thyroid Cancer Treatment Choice: A Pilot Study of a Tool to Facilitate Conversations with Patients with Papillary Microcarcinomas Considering Treatment Options.

Authors:  Juan P Brito; Jae Hoon Moon; Rebecca Zeuren; Sung Hye Kong; Yeo Goon Kim; Nicole M Iñiguez-Ariza; June Young Choi; Kyu Eun Lee; Ji-Hoon Kim; Ian Hargraves; Victor Bernet; Victor M Montori; Young Joo Park; R Michael Tuttle
Journal:  Thyroid       Date:  2018-07-25       Impact factor: 6.568

8.  Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells.

Authors:  JaeJin An; Eun-Mi Ha
Journal:  J Microbiol Biotechnol       Date:  2016-08-28       Impact factor: 2.351

9.  Diet and colorectal cancer in UK Biobank: a prospective study.

Authors:  Kathryn E Bradbury; Neil Murphy; Timothy J Key
Journal:  Int J Epidemiol       Date:  2020-02-01       Impact factor: 7.196

Review 10.  "Driver-passenger" bacteria and their metabolites in the pathogenesis of colorectal cancer.

Authors:  Marion Avril; R William DePaolo
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.